Associate Professor, Medicine, University of Colorado School of Medicine
Hematology
Dr. Thomas J. Braun, MD
|
|
Give Review
Thomas Braun works in the field of Hematology. He went to University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a top medical university. University of Colorado Denver School of Medicine has a rank of 35 in research and a 8 in primary care Thomas J. Braun, MD is also published. He has 14 publications published. The lastest publication: "Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest On...'
Publications
- Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
- FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
- Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute Myeloid leukemia in rem...
- Periodontal Health in Women With Early Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study.
- Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung.
- Engraftment Syndrome after Allogeneic Hematopoietic Cell Transplantation Predicts Poor Outcomes.
- Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell ...
- SWOG-9510: evaluation of topotecan in hormone refractory prostate Cancer: a Southwest Oncology Group study.
- A phase II trial of recombinant tumor necrosis factor in patients with metastatic coloRectal adenocarcinoma: a Southwest Oncology Group study.
- A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study.
- Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung Cancer: results of a phase II Southwest On...
- Evaluation of amonafide in refractory and relapsing multiple Myeloma: a Southwest Oncology Group study.
Schools
UNIVERSITY OF COLORADO AT DENVER
University Colo Med Center
Meml Sloan Kettering Cancer
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Chronic Myeloid Leukemia (CML)
- ColoRectal Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Memorial Sloan-Kettering Cancer Center -
University of Colorado -
University of Colorado Denver School of Medicine
Hospital
-
University of Colorado Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Robert L. Garcea, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Scott I. Bearman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rodabe N. Amaria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah J. Conlon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle L. Klem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew Eadens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellina K. Hall, DO |
|
|
Dr. Christiane D. Thienelt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Devchand Paul, DO |
|
|
Dr. Gretchen A. Mann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Shaia, MD |
|
|
Dr. Paul Seligman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alan S. Feiner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael B. Maris, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Timothy W. Morgan, MD |
|
Dr. Peter A. McSweeney, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Christopher L. Gonzalez, MD |